No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs571387324 |
chr10:116519751-116519752 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs533530696 |
chr10:116519823-116519824 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs145616990 |
chr10:116519911-116519912 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs190909873 |
chr10:116519915-116519916 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs183236305 |
chr10:116519962-116519963 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs553767047 |
chr10:116519980-116519981 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs188160490 |
chr10:116519982-116519983 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs567535756 |
chr10:116520015-116520016 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs537875103 |
chr10:116520031-116520032 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs556207849 |
chr10:116520049-116520050 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs113303502 |
chr10:116520075-116520076 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs73373774 |
chr10:116520125-116520126 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs141062346 |
chr10:116520139-116520140 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs376885872 |
chr10:116520164-116520165 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs573903656 |
chr10:116520167-116520168 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs3981296 |
chr10:116520197-116520198 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs58286785 |
chr10:116520199-116520200 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs71007490 |
chr10:116520203-116520204 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs80214827 |
chr10:116520208-116520209 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs542548397 |
chr10:116520213-116520214 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs561265800 |
chr10:116520251-116520252 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs531306578 |
chr10:116520264-116520265 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs543457396 |
chr10:116520280-116520281 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs368565154 |
chr10:116520294-116520295 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs553242029 |
chr10:116520311-116520312 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs564933927 |
chr10:116520332-116520333 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs532250518 |
chr10:116520370-116520371 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs547519965 |
chr10:116520465-116520466 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs182879121 |
chr10:116520508-116520509 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs117773512 |
chr10:116520536-116520537 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs549388250 |
chr10:116520573-116520574 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs567968551 |
chr10:116520621-116520622 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs537810736 |
chr10:116520778-116520779 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs542255700 |
chr10:116520849-116520850 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs540870778 |
chr10:116520871-116520872 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs144603460 |
chr10:116520894-116520895 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs187555933 |
chr10:116520932-116520933 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs538741874 |
chr10:116520936-116520937 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs139024248 |
chr10:116520937-116520938 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs808300 |
chr10:116520963-116520964 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs147884530 |
chr10:116520967-116520968 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs140484700 |
chr10:116521023-116521024 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs562630488 |
chr10:116521025-116521026 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs80330493 |
chr10:116521026-116521027 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs398046260 |
chr10:116521037-116521038 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs397725863 |
chr10:116521038-116521039 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs554533198 |
chr10:116521067-116521068 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs576424552 |
chr10:116521127-116521128 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs74158052 |
chr10:116521129-116521130 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs79950178 |
chr10:116521160-116521161 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|